|
1
|
Jemal A, Siegel R, Ward E, Murray T, Xu J,
Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin.
56:106–130. 2006. View Article : Google Scholar
|
|
2
|
Zhang J, Dhaka IB, Zhao Z and Li L: Trends
in mortality from cancers of the breast, colon, prostate,
esophagus, and stomach in East Asia: role of nutrition transition.
Eur J Cancer Prev. 21:480–489. 2012. View Article : Google Scholar
|
|
3
|
Foretova L, Petrakova K, Palacova M,
Kalabova R, Svoboda M, Navratilova M, Schneiderova M, Bolcak K,
Krejci E, Drazan L, Mikova M, Hazova J, Vasickova P and Machackova
E: Genetic testing and prevention of hereditary cancer at the MMCI
- over 10 years of experience. Klin Onkol. 23:388–400.
2012.PubMed/NCBI
|
|
4
|
Glück S and Mamounas T: Improving outcomes
in early-stage breast cancer. Oncology (Williston Park). 24(Suppl
4): 1–15. 2010.
|
|
5
|
Brunetto de Farias C, Rosemberg DB, Heinen
TE, Koehler-Santos P, Abujamra AL, Kapczinski F, Brunetto AL,
Ashton-Prolla P, Meurer L, Reis Bogo M, Damin DC, Schwartsmann G
and Roesler R: BDNF/TrkB content and interaction with
gastrin-releasing peptide receptor blockade in colorectal cancer.
Oncology. 79:430–439. 2010.PubMed/NCBI
|
|
6
|
Barde YA, Edgar D and Thoenen H:
Purification of a new neurotrophic factor from mammalian brain.
EMBO J. 1:549–553. 1982.PubMed/NCBI
|
|
7
|
Numakawa T, Suzuki S, Kumamaru E, Adachi
N, Richards M and Kunugi H: BDNF function and intracellular
signaling in neurons. Histol Histopathol. 25:237–258.
2010.PubMed/NCBI
|
|
8
|
Huang YT, Lai PC, Wu CC, Hsu SH, Cheng CC,
Lan YF and Chiu TH: BDNF mediated TrkB activation is a survival
signal for transitional cell carcinoma cells. Int J Oncol.
36:1469–1476. 2010.PubMed/NCBI
|
|
9
|
Sun CY, Hu Y, Huang J, Chu ZB, Zhang L,
She XM and Chen L: Brain-derived neurotrophic factor induces
proliferation, migration, and VEGF secretion in human multiple
myeloma cells via activation of MEK-ERK and PI3K/AKT signaling.
Tumour Biol. 31:121–128. 2010. View Article : Google Scholar
|
|
10
|
Zhang L, Hu Y, Sun CY, Huang J and Chu ZB:
Brain-derived neurotrophic factor promotes the secretion of MMP-9
in human myeloma cell through modulation of nucleus factor-kappaB.
Zhonghua Xue Ye Xue Za Zhi. 29:243–246. 2008.(In Chinese).
|
|
11
|
Zhang S, Guo D, Luo W, Zhang Q, Zhang Y,
Li C, Lu Y, Cui Z and Qiu X: TrkB is highly expressed in NSCLC and
mediates BDNF-induced the activation of Pyk2 signaling and the
invasion of A549 cells. BMC Cancer. 10:432010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Akil H, Perraud A, Mélin C, Jauberteau MO
and Mathonnet M: Fine-tuning roles of endogenous brain-derived
neurotrophic factor, TrkB and sortilin in colorectal cancer cell
survival. PLoS One. 6:e250972011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Festuccia C, Gravina GL, Millimaggi D,
Muzi P, Speca S, Ricevuto E, Vicentini C and Bologna M: Uncoupling
of the epidermal growth factor receptor from downstream signal
transduction molecules guides the acquired resistance to gefitinib
in prostate cancer cells. Oncol Rep. 18:503–511. 2007.
|
|
14
|
Li Z, Zhang J, Liu Z, Woo CW and Thiele
CJ: Downregulation of Bim by brain-derived neurotrophic factor
activation of TrkB protects neuroblastoma cells from paclitaxel but
not etoposide or cisplatin-induced cell death. Cell Death Differ.
14:318–326. 2007. View Article : Google Scholar
|
|
15
|
Patani N, Jiang WG and Mokbel K:
Brain-derived neurotrophic factor expression predicts adverse
pathological & clinical outcomes in human breast cancer. Cancer
Cell Int. 11:232011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo D, Hou X, Zhang H, Sun W, Zhu L, Liang
J and Jiang X: More expressions of BDNF and TrkB in multiple
hepatocellular carcinoma and anti-BDNF or K252a induced apoptosis,
supressed invasion of HepG2 and HCCLM3 cells. J Exp Clin Cancer
Res. 30:972011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kawamura N, Kawamura K, Manabe M and
Tanaka T: Inhibition of brain-derived neurotrophic factor/tyrosine
kinase B signaling suppresses choriocarcinoma cell growth.
Endocrinology. 151:3006–3014. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Z and Thiele CJ: Targeting Akt to
increase the sensitivity of neuroblastoma to chemotherapy: lessons
learned from the brain-derived neurotrophic factor/TrkB signal
transduction pathway. Expert Opin Ther Targets. 11:1611–1621. 2007.
View Article : Google Scholar
|
|
19
|
Sheikh AM, Malik M, Wen G, Chauhan A,
Chauhan V, Gong CX, Liu F, Brown WT and Li X: BDNF-Akt-Bcl2
antiapoptotic signaling pathway is compromised in the brain of
autistic subjects. J Neurosci Res. 88:2641–2647. 2010.PubMed/NCBI
|
|
20
|
Yu X, Liu L, Cai B, He Y and Wan X:
Suppression of anoikis by the neurotrophic receptor TrkB in human
ovarian cancer. Cancer Sci. 99:543–552. 2008. View Article : Google Scholar : PubMed/NCBI
|
